Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Edison Pharmaceuticals closes its $4.25mm Series B financing

Executive Summary

Edison Pharmaceuticals (inherited mitochondrial diseases) has raised $4.25mm through the closing of its Series B venture round. The preferred shares were sold to Carl Berg of Berg & Berg Enterprises (lead) and new investor John W. Marriott, III, president and CEO of JWM and JWM Family Enterprises.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies